Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Respiratory Disease Therapeutics. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102336705B reveals a novel amidation route for Roflumilast using activated esters, offering superior purity and cost-effective manufacturing for global supply chains.
Patent CN1968927B details a novel Ru-catalyzed route for high-purity quinoline intermediates used in bronchodilators, offering significant cost reduction in API manufacturing.
Patent CN102336703B details a green Bi2O3-catalyzed oxidation and HATU coupling route for Roflumilast, offering superior yield and supply chain reliability for global pharma buyers.